News
Important Only
3 Millionaire-Maker Technology Stocks Worth a Closer Look
Key PointsIonQ could become one of the biggest winners in quantum computing.UiPath has a huge opportunity in the agentic AI field. GitLab looks misunderstood. 10 stocks we like better than IonQ › If you're looking for some potential millionaire-making stocks to invest in, you can just settle for ave...The Motley Fool
Thu, Jan 22
Surf Air Mobility up on Mokulele Airlines investment
Shares of electric aircraft charter company Surf Air Mobility SRFM.N rise 4.5% to $2.5 premarket Co says will invest $22.4 million by the end of 2026 into Mokulele Airlines operationsInvestment to maintain service reliability, improve customer experience and optimize the network for the deployment o...Reuters
Thu, Jan 22
Axogen slides on surgical device maker's $124 mln stock sale
Shares of surgical device maker Axogen AXGN.O down 7.2% at $30.62 premarket after $124 mln overnight follow-on priced Florida-based firm late Weds announced 4 mln shares at $31 Offering size increased from $85 mln, and priced at 6.1% discount to stock's last sale It intends to use...Reuters
Thu, Jan 22
Janux Therapeutics, Bristol Myers enter up to $850 million deal to develop cancer drug
Jan 22 (Reuters) - Janux Therapeutics JANX.O said on Thursday it has entered a collaboration with Bristol Myers Squibb BMY.N to develop a new cancer treatment, sending its shares up more than 12% in premarket trading.The therapy is intended to treat "solid tumors" - meaning cancers that form...Reuters
Thu, Jan 22
US STOCKS-Wall St futures rise further on Greenland relief; data in focus
Futures up: Dow 0.25%, S&P 500 0.47%, Nasdaq 0.75%McCormick forecasts weak annual profit on tariffsProcter & Gamble Q2 revenue is a touch shy of estimatesNovember PCE figures due at 10:00 a.m ETBy Sruthi Shankar and Pranav Kashyap Jan 22 (Reuters) - U.S. stock index futures climbed on...Reuters
Thu, Jan 22
Janux shares rise on global cancer drug deal with Bristol Myers
Shares of drug developer Janux Therapeutics JANX.O rise 17.33% to $15.57 premarket Co says it signed a global licensing deal with Bristol Myers BMY.N to develop a new solid-tumor cancer drug Co says it may receive up to $50 mln upfront and near-term milestones, plus as much as $800 mln more tied to ...Reuters
Thu, Jan 22
2 Cheap Tech Stocks to Buy Right Now
Key PointsDuolingo has nearly 130 million monthly active users but trades at just 20 times free cash flow.Kyndryl's hyperscaler revenue doubled year over year while margins expanded to 17.2%, and the stock is dirt cheap.Neither company is broken; both are out of favor and trading at bargain valuatio...The Motley Fool
Thu, Jan 22
McCormick down after forecasting annual profit below expectations
Shares of Cholula sauce maker McCormick MKC.N down 5.5% at $62.90 premarketCo forecasts annual profit below expectations and reports Q4 profit miss due to impact from tariffs and higher input costsSees annual adjusted EPS between $3.05 to $3.13 vs. analysts' estimates of $3.22 - data compiled by...Reuters
Thu, Jan 22
Datadog gains; Stifel raises to 'buy'
Cloud security firm Datadog's DDOG.O shares rise 3.1% to $127.27 premarketStifel upgrades stock to "buy" from "hold"Cuts PT to $160 from $205, still implying an upside of 29.6% to stock's last closeAverage rating of 43 analysts is "buy," their median PT is $204.35 - d...Reuters
Thu, Jan 22
Is JPMorgan Chase Stock a Millionaire-Maker?
Key PointsJPMorgan Chase reported Q4 financial results that beat Wall Street estimates. A cost advantage and switching costs support the company’s economic moat. Shares trade at a steep price-to-book ratio.10 stocks we like better than JPMorgan Chase › With $4.4 trillion in assets (as of Dec. 31), J...The Motley Fool
Thu, Jan 22
Invivyd rises after team-up with Olympic skier Lindsey Vonn
Shares of drugmaker Invivyd IVVD.O rise 2.26% to $2.26 premarketCo says it has partnered with Olympic gold medalist Lindsey Vonn to launch a national campaign educating Americans on antibodies, which are proteins the body uses to fight infectionsThe spring 2026 campaign will feature Vonn as spokespe...Reuters
Thu, Jan 22
Macron's 'Top Gun' look gives glasses maker's stock $4 million bump
PARIS, Jan 22 (Reuters) - Emmanuel Macron's aviator sunglasses drove the shares of their maker, iVision Tech IVN.MI, almost 28% higher on Thursday after the French president's look during his speech at the annual World Economic Forum in Davos went viral online.The group, which owns French hi...Reuters
Thu, Jan 22
Mobileye Global falls on lower-than-expected annual revenue forecast
Shares of self-driving tech company Mobileye Global MBLY.O fall 6.4% to $10.16 premarketMBLY expects 2026 revenue between $1.90 bln and $1.98 bln, compared with analysts' avg. est of $2 bln - LSEG-compiled dataCo says its FY25 rev. up 15% Y/Y at $1.89 billionMBLY stock had fallen ~48% in 2025Reuters
Thu, Jan 22
LIVE MARKETS-Keep snapping up weakness in EU defence stocks - JPM
STOXX up 1%, Trump steps back from Greenland linked tariff threats Auto stocks up 1.8%, defence stocks flat U.S. futures higher Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.comKEEP SN...Reuters
Thu, Jan 22
If a Stock Market Crash Is Coming in 2026, There's a Major Silver Lining for Investors
Key PointsThe stock market can be unpredictable, but there are a few warning signs investors may want to watch.Investing in the right places is key to surviving a bear market or recession.While downturns are intimidating, they can also create new opportunities for investors.These 10 stocks could min...The Motley Fool
Thu, Jan 22
Erasca continues ascent after cancer therapy co's upsized $225 mln stock offering
Erasca ERAS.O shares up 3.1% before the bell to $10.36 after above-target $225 mln equity raise ERAS shares poised to rise for 7th straight session, if gains hold San Diego, California-based precision oncology co late Weds announced pricing 22.5 mln shares at $10 ERAS shares on We...Reuters
Thu, Jan 22
If You'd Invested $1,000 in Cameco Stock 10 Years Ago, Here's How Much You'd Have Today
Key PointsPresident Trump's aim to quadruple U.S. nuclear energy capacity by 2050 could be the biggest tailwind Cameco has ever seen. Cameco's dominance in uranium and its stake in Westinghouse should send the stock higher. 10 stocks we like better than Cameco › Over the 10 years through 2020, Camec...The Motley Fool
Thu, Jan 22
Citi cuts Microsoft PT on weak PC market forecast, OpenAI-related costs
Citi cuts PT on Microsoft MSFT.O to $660 from $690; still implies ~49% upside to stock's last close Brokerage remains "constructive" on MSFT and is positive on cloud business Azure's long-term growth, but expects a weaker PC market and higher expenses related to OpenAIAdds that while...Reuters
Thu, Jan 22
U.S. STOCKS ON THE MOVE-Micron, Rambus, GE Aerospace
The Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv/3dKUyB8U.S. stock index futures rose on Thursday, signaling fresh buying momentum on Wall Street after President Donald Trump backed down from threats to impose tariffs against European countries, ...Reuters
Thu, Jan 22
This Is the Average 401(k) Balance for Retirees (and Others) Aged 58 and Older
Key PointsMost 50-somethings have not socked away enough money in their 401(k)s yet.That's especially true when you examine median figures instead of average figures.The $23,760 Social Security bonus most retirees completely overlook › In your late 50s? Then retirement may be just a few years away, ...The Motley Fool
Thu, Jan 22
